Global ampoules and syringes market is expected to grow at a compound annual growth rate of 6.43% to reach a market size of US$7.909 billion by 2024 from US$5.441 billion in 2018.
The rising number of health issues owing to the unhealthy lifestyle is expected to drive the market for ampoules and syringes. Further, growing geriatric population is also one of the factors fuelling the market. Moreover, the increased adoption of injectable drugs coupled with growing number of vaccinations across the globe is anticipated to boost the market in the coming years. The growing preference for safe transportation of medicines is also a factor propelling the demand for ampoules.
Additionally, technological advancements like advent of smart syringes is expected to widen up the growth opportunities for the market. However, presence of alternatives is anticipated to hamper the market growth.
The market has been segmented by product type, size, end user and geography. In the product type segment, the plastic syringes and plastic ampoules are expected grow substantially on account of the wide usage of these ampoules and syringes in hospitals and other medical institutes. Further, in the end user segment, hospitals are projected to hold significant share on account of the rising number of patients leading to growing usage of syringes and ampoules.
Geographically, Asia Pacific is projected to grow at a notable rate due to the rising infrastructure activities for hospitals and manufacturing of syringes and ampoules in developing countries like India and China.
The major players profiled in the Ampoules and Syringes market include Terumo Corporation, B. Braun Melsungen AG, Zeon Corporation, Baxter International Inc., Topas Advanced Polymers Gmbh, Stevanato Group, Schott AG, Becton, Dickinson and Company, West Pharmaceutical Services Inc., Gerresheimer AG, Hindustan Syringes & Medical Devices Ltd., Lifelong Meditech Private Ltd. and NIPRO Corporation among others.
- Growing number of chronic diseases
- Budding healthcare industry
- Availability of substitutes
- In December 2018, Terumo Corporation launched PLAJEX pre-fillable Syringes in Europe.
- Terumo Corporation announced a capital investment of 7 billion Yen for construction of an additional production facility for pre-filled syringes at the headquarters plant at Terumo Yamaguchi D&D Corporation, a Terumo subsidiary.
Key Topics Covered
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis – Regional Snapshot
4.7. Market Attractiveness
5. AMPOULES AND SYRINGES MARKET BY PRODUCT TYPE
5.1.1. Glass Ampoules
5.1.2. Plastic ampoules
5.2.1. Glass Syringes
5.2.2. Plastic Syringes
6. AMPOULES AND SYRINGES MARKET BY SIZE
6.1.2. 5-10 ml
6.1.3. Above 10 ml
6.2.1. 1-10 cc
6.2.2. 10-30 cc
6.2.3. 30 cc and above
7. AMPOULES AND SYRINGES BY END USER
7.1. Hospitals & Clinics
7.2. Healthcare Centers
7.3. Ambulatory Services
8. AMPOULES AND SYRINGES MARKET BY GEOGRAPHY
8.1. North America
8.2. South America
8.4. Middle East and Africa
8.5. Asia Pacific
9. COMPETITIVE INTELLIGENCE
9.1. Competitive Benchmarking and Analysis
9.2. Recent Investments and Deals
9.3. Strategies of Key Players
10. COMPANY PROFILES
10.1. Terumo Corporation
10.2. B. Braun Melsungen AG
10.3. Zeon Corporation
10.4. Baxter International Inc.
10.5. Topas Advanced Polymers Gmbh
10.6. Stevanato Group
10.7. Schott AG
10.8. Becton, Dickinson and Company
10.9. West Pharmaceutical Services Inc.
10.10. Gerresheimer AG
10.11. Hindustan Syringes & Medical Devices Ltd.
10.12. Lifelong Meditech Private Ltd.
10.13. NIPRO Corporation
10.14. Global Pharmatech Pvt. Ltd.
10.15. SGD Pharma
For more information about this report visit here.